Sharp Clinical Services (UK)
Sharp Clinical Services (UK) is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of MBS2320 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
Operational learnings available2 trial-level findings · Read insights
- The study assessed 2 patients and treated 1 patient before termination.
- Delayed study start-up and slow patient recruitment prevented completion of planned enrollment on time.
These findings describe the trial, not the service provider’s performance or responsibility.
A long-term, double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of PQ Grass 27600 SU in children and adolescents with seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
Sponsor Allergy Therapeutics (UK) Limited
- Start (EU)
- Latest update
- Estimated end
A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children from 1 to Less Than 18 Years of Age With PAH on Standard of Care
Sponsor Merck Sharp & Dohme LLC
- Start (EU)
- Latest update
- Estimated end
An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of WEF-001 in participants with Advanced KRAS- Mutant Solid Tumours.
Sponsor Auricula Biosciences Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN7544, an Antagonist Monoclonal Antibody to NPR1, in Patients with Sepsis-Induced Hypotension
Sponsor Regeneron Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided phase 2 study
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of WEF-001 in participants with Advanced KRAS- Mutant Solid Tumours.
Sponsor Auricula Biosciences Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure
Sponsor Allergy Therapeutics (UK) Limited
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Sharp Clinical Services (UK)?
The 2026-10-09 snapshot links Sharp Clinical Services (UK) to 8 distinct CTIS trials. Recorded services include Labelling and packaging, Labelling, Packing, Depot/Storage, and Distribution services of Study IMP., Clinical supplies distribution, release, return, Laboratory services, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sharp Clinical Services (UK)?
The most frequently recorded therapeutic areas are Respiratory, Allergy, Cardiology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sharp Clinical Services (UK) conducted?
The linked trials record locations in 15 countries, including Germany, Spain, France, Poland, Czechia. These are trial locations, not confirmed office locations or countries where Sharp Clinical Services (UK) delivered services.
What can this page tell me about Sharp Clinical Services (UK)'s trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sharp Clinical Services (UK). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sharp Clinical Services (UK) Limited